Literature DB >> 31300954

Use of Continuous Metabolic Syndrome Score in Overweight and Obese Children.

Sangeeta P Sawant1, Alpa S Amin2.   

Abstract

OBJECTIVE: To assess the utility of continuous metabolic syndrome score (cMetS) for predicting metabolic syndrome (MS) and determine the cut-off values in overweight and obese children.
METHODS: This study was conducted among 104 children (7-14 y) attending obesity clinics of a tertiary care hospital in Mumbai, India. The cMetS was computed by standardizing the residuals of waist circumference (WC), mean arterial blood pressure (MAP), high density lipoprotein cholesterol (HDL-C), triglycerides (TG), and Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) by regressing them according to age and sex and aggregating them. The optimal cut-off of cMetS for predicting MS was determined by the receiver operation characteristic (ROC) curve analysis.
RESULTS: The cMetS increased significantly with increase in the number of MS risk factors. It was significantly high in children with MS than those without it (boys: 1.070 + 1.834 vs. -1.478 + 2.262; girls: 2.092 + 1.963 vs. -2.253 + 2.140; combined children group: 1.572 + 1.950 vs. -1.907+ 2.374; p < 0.001). The score predicted MS with high accuracy in girls; (AUC of 0.95, 95% CI: 0.90-1.00), moderate accuracy in boys (AUC of 0.79, 95% CI: 0.65-0.92) and in the combined group (AUC of 0.87, 95% CI 0.80-0.94) respectively. The cut-off of cMetS yielding maximal sensitivity and specificity for predicting the MS was -1.009 in boys (sensitivity 93% and specificity 62%); -0.652 in girls (sensitivity 96.4% and specificity 77%) and - 0.6881 in the combined group (sensitivity 91.2% and specificity 70.2%).
CONCLUSIONS: cMetS predicted MS with moderate to high accuracy. It had high sensitivity and specificity in predicting MS in overweight and obese children.

Entities:  

Keywords:  Children; Continuous metabolic syndrome score; Metabolic syndrome; Obesity; Overweight

Mesh:

Substances:

Year:  2019        PMID: 31300954     DOI: 10.1007/s12098-019-02994-5

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  22 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

2.  Continuous and Dichotomous Metabolic Syndrome Definitions in Youth Predict Adult Type 2 Diabetes and Carotid Artery Intima Media Thickness: The Cardiovascular Risk in Young Finns Study.

Authors:  Costan G Magnussen; Sanith Cheriyan; Matthew A Sabin; Markus Juonala; Juha Koskinen; Russell Thomson; Michael R Skilton; Mika Kähönen; Tomi Laitinen; Leena Taittonen; Nina Hutri-Kähönen; Jorma S A Viikari; Olli T Raitakari
Journal:  J Pediatr       Date:  2015-12-09       Impact factor: 4.406

Review 3.  Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence.

Authors:  Earl S Ford
Journal:  Diabetes Care       Date:  2005-07       Impact factor: 19.112

4.  Homeostatic Model Assessment for Insulin Resistance (HOMA-IR): A Better Marker for Evaluating Insulin Resistance Than Fasting Insulin in Women with Polycystic Ovarian Syndrome.

Authors:  Hafsa Majid; Qamar Masood; Aysha Habib Khan
Journal:  J Coll Physicians Surg Pak       Date:  2017-03       Impact factor: 0.711

5.  Efficacy of a continuous metabolic syndrome score in Indian children for detecting subclinical atherosclerotic risk.

Authors:  D Pandit; S Chiplonkar; A Khadilkar; A Kinare; V Khadilkar
Journal:  Int J Obes (Lond)       Date:  2011-07-19       Impact factor: 5.095

6.  Reference values for cardiometabolic risk scores in children and adolescents: Suggesting a common standard.

Authors:  Mette Stavnsbo; Geir K Resaland; Sigmund A Anderssen; Jostein Steene-Johannessen; Sidsel L Domazet; Turid Skrede; Luis B Sardinha; Susi Kriemler; Ulf Ekelund; Lars B Andersen; Eivind Aadland
Journal:  Atherosclerosis       Date:  2018-10-06       Impact factor: 5.162

7.  Metabolic syndrome in obese children and adolescents: dichotomous or continuous?

Authors:  David Thivel; Robert M Malina; Laurie Isacco; Julien Aucouturier; Martine Meyer; Pascale Duché
Journal:  Metab Syndr Relat Disord       Date:  2009-12       Impact factor: 1.894

8.  Report of the Second Task Force on Blood Pressure Control in Children--1987. Task Force on Blood Pressure Control in Children. National Heart, Lung, and Blood Institute, Bethesda, Maryland.

Authors: 
Journal:  Pediatrics       Date:  1987-01       Impact factor: 7.124

9.  Predictors of metabolically healthy obesity in children.

Authors:  Rhiannon L Prince; Jennifer L Kuk; Kathryn A Ambler; Jasmine Dhaliwal; Geoff D C Ball
Journal:  Diabetes Care       Date:  2014-02-26       Impact factor: 19.112

10.  Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey.

Authors:  Sarah D de Ferranti; Kimberlee Gauvreau; David S Ludwig; Ellis J Neufeld; Jane W Newburger; Nader Rifai
Journal:  Circulation       Date:  2004-10-11       Impact factor: 29.690

View more
  3 in total

1.  Continuous Metabolic Syndrome Score in Children: How Useful is it?

Authors:  Rajni Sharma
Journal:  Indian J Pediatr       Date:  2019-08-03       Impact factor: 1.967

2.  Metabolic syndrome and risk factors in children: a risk score proposal.

Authors:  Larissa Pereira Lourenço; Poliana Cristina de Almeida Fonseca Viola; Sylvia do Carmo Castro Franceschini; Carla de Oliveira Barbosa Rosa; Sarah Aparecida Vieira Ribeiro
Journal:  Eur J Clin Nutr       Date:  2022-10-06       Impact factor: 4.884

3.  Validity of continuous metabolic syndrome score for predicting metabolic syndrome; a systematic review and meta-analysis.

Authors:  Maryam Khazdouz; Motahareh Hasani; Sanaz Mehranfar; Hanieh-Sadat Ejtahed; Shirin Djalalinia; Armita Mahdavi Gorabi; Mohammad Esmaeili-Abdar; Shahrokh Karbalahi Saleh; Seyed Masoud Arzaghi; Hoda Zahedi; Amir Kasaeian; Mostafa Qorbani
Journal:  J Diabetes Metab Disord       Date:  2021-04-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.